Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N5TB
|
||||
Former ID |
DIB003599
|
||||
Drug Name |
ITRI-305
|
||||
Synonyms |
ITRI-305; RET tyrosine kinase inhibitors, Industrial Technology Research Institute
|
||||
Indication | Thyroid cancer [ICD9: 140-229, 193; ICD10:C73] | Investigative | [543572] | ||
Company |
Industrial Technology Research Institute
|
||||
Target and Pathway | |||||
Target(s) | Proto-oncogene tyrosine-protein kinase receptor ret | Target Info | Inhibitor | [543572] | |
WikiPathways | SIDS Susceptibility Pathways | ||||
Dopaminergic Neurogenesis | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.